For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb0451Ca&default-theme=true
RNS Number : 0451C Fevertree Drinks PLC 28 April 2026
28(th) April 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 20(th)
April to 24(th) April 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
20 April 2026 XLON 860.1812 26,797 851.5000 867.0000
21 April 2026 XLON 854.8762 19,100 843.5000 870.0000
21 April 2026 AIMX 863.0000 20,795 863.0000 863.0000
22 April 2026 XLON 836.5579 24,191 829.5000 862.0000
22 April 2026 AIMX 830.5000 17,809 830.5000 830.5000
23 April 2026 XLON 834.5318 19,259 820.0000 844.0000
23 April 2026 AIMX 825.0000 15,000 825.0000 825.0000
24 April 2026 XLON 836.2185 31,003 828.5000 844.0000
24 April 2026 AIMX 830.0000 10,000 830.0000 830.0000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/0451C_1-2026-4-27.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/0451C_1-2026-4-27.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSBDLFLQZLBBBZ
Copyright 2019 Regulatory News Service, all rights reserved